KEY HEDGE FUNDS have jumped into Sarepta Therapeutics Inc HeadFirst. Read .
Insider Monkey :This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT): Acorda Therapeutics Inc (ACOR), Nektar Therapeutics (NKTR)
By Arnold Frias in News
Published: April 3, 2013 at 6:32 am
As aggregate interest increased, key hedge funds have jumped into Sarepta Therapeutics Inc (NASDAQ:SRPT) headfirst. Deerfield Management, managed by James E. Flynn, created the most valuable position in Sarepta Therapeutics Inc (NASDAQ:SRPT). Deerfield Management had 19 million invested in thecompany at the end of the quarter. Phill Gross and Robert Atchinson's Adage Capital Management also initiated a $10 million position during the quarter. The other funds with brand new SRPT positions are Joseph Edelman's Perceptive Advisors, Jacob Gottlieb's Visium Asset Management, and Christopher Medlock James's Partner Fund Management